Edgar Grinstein
Impact in
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Oncology top 5%
- Viral-associated cancers and disorders
- Cancer-related Molecular Pathways
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Cell death mechanisms and regulation 4
- RNA Interference and Gene Delivery 2
- Oncology 9
- Cancer-related Molecular Pathways 6
- Cancer Cells and Metastasis 2
- Co-authors
- Hans‐Dieter Royer (4 shared papers)Markus Y. Mapara (2 shared papers)Ralf C. Bargou (2 shared papers)Kurt Bommert (2 shared papers)Florian Emmerich (1 shared paper)Claus Scheidereit (1 shared paper)Bernd Dörken (1 shared paper)Andreas Greiner (1 shared paper)
- Journals
- Journal of Biological Chemistry (4 papers)The Journal of Experimental Medicine (3 papers)Cellular Signalling (2 papers)Leukemia (2 papers)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Edgar Grinstein
18 papers receiving 1.2k citations
Edgar Grinstein's Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 386
- Oncology 417
- Pathology and Forensic Medicine 237
- Immunology 253
- Molecular Biology 642
Countries citing papers authored by Edgar Grinstein
This map shows the geographic impact of Edgar Grinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Grinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Grinstein more than expected).
Fields of papers citing papers by Edgar Grinstein
This network shows the impact of papers produced by Edgar Grinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Grinstein. The network helps show where Edgar Grinstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Edgar Grinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. Hit paper breakdown → | 1997 | 674 |
| 2 | 2000 | 122 | |
| 3 | 2002 | 95 | |
| 4 | 2002 | 62 | |
| 5 | 2007 | 46 | |
| 6 | 2007 | 44 | |
| 7 | 2006 | 40 | |
| 8 | 1996 | 29 | |
| 9 | Stem cell divisions controlled by the proto-oncogene BMI-1. | 2009 | 26 |
| 10 | 2015 | 19 | |
| 11 | 2009 | 16 | |
| 12 | 2009 | 16 | |
| 13 | 2018 | 11 | |
| 14 | 1996 | 8 | |
| 15 | 2011 | 8 | |
| 16 | 2007 | 7 | |
| 17 | 2011 | 4 | |
| 18 | 1995 | 3 | |
| 19 | 2023 | 0 |
About Edgar Grinstein
Edgar Grinstein is a scholar working on Molecular Biology, Oncology, Immunology, Cell Biology and Cancer Research, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), T-cell and B-cell Immunology (4 papers), Cell death mechanisms and regulation (4 papers), Virus-based gene therapy research (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), RNA Interference and Gene Delivery (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (386 citations), Oncology (417 citations), Pathology and Forensic Medicine (237 citations), Immunology (253 citations) and Molecular Biology (642 citations). Edgar Grinstein has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Hans‐Dieter Royer, Markus Y. Mapara, Ralf C. Bargou, Kurt Bommert, Florian Emmerich, Claus Scheidereit, Bernd Dörken, Andreas Greiner, Daniel Krappmann and W Arnold. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine, Cellular Signalling, Leukemia and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.